Community/Retail

As the profession moves more toward the internet, it is helpful to know how to best use the various platforms.

Jeffrey B. Simon, JD, co-chair of the National Opioid Litigation Conference, discusses some steps that pharmacists could take to help address the opioid epidemic in the pharmacy.

Moderna expects to enroll approximately 375 participants in about 20 sites across the United States.

Vitamin B9 levels should be regularly checked to correct any deficiencies in older age.

Singulair is a leukotriene receptor antagonist indicated for prophylaxis and chronic treatment of asthma.

Systane is a lubricating eye drop indicated for dry eye relief.

Our first on-location podcast episode featuring 2 prolific women in the pharmacy world!

Just culture framework helps to balance safety and accountability in medication error by identifying the root cause without blaming an individual.

Factors such as economic stability and education access can be categorized into social determinants of health.

Pharmacy leadership remaining mindful, connected, and engaged is crucial to support the mental health needs of their staff.

Daniel Krinsky, MS, owner and president of EduCare4U and PGx101, and Stefanie Ferreri, PharmD, Smith and Olsen Distinguished professor at the Eshelman School of Pharmacy in the University of North Carolina, discuss the additions, removals, and changed to OTC products in the past 2 years.

Opening the door for communication in a nonjudgmental manner is essential for pharmacists to counsel patients on cannabis use.

Session at the American Pharmacists Association Annual Meeting discusses the importance of naloxone in reducing the burden of the opioid epidemic.

A presentation at the American Pharmacists Association Annual Meeting 2022, highlighted potential innovations for community pharmacies.

Jeffrey B. Simon, JD, co-chair of the National Opioid Litigation Conference, discusses what the National Opioid Litigation Conference is and what its involvement is in opioid lawsuits across the country.

Question Before the Court: is police detention legally permissible, or does it constitute an unlawful arrest?

Moderna seeks EUA for its Spikevax COVID-19 vaccine for a fourth booster dose in individuals 18 years of age and older who have received an initial booster of any authorized or approved COVID-19 vaccine.

Managing your finances is not only important after graduating pharmacy school, but for years after when other factors come into play.

Cortizone-10 is used to treat a variety of skin conditions.

Michele Belcher, president of the National Community Pharmacists Association, and pharmacist and pharmacy owner at Grants Pass Pharmacy, discusses ways of transforming the pharmacy profession’s current challenges into opportunities for positive change for the profession.

Implementation, communication, and assessment are critical steps to ensure patient safety.

Michael Abrams, MPH, PhD, senior health researcher at Public Citizen’s Health Research Group, discusses actions needed to help manage the opioid epidemic in the country.

Phase 3 trial results also indicate that Alzheimer disease clinical decline was reduced in participants who had plasma p-tau181 reduction at 78 weeks.

Trial of empagliflozin (Jardiance) in adults with chronic kidney disease will end early based on a recommendation from the trial’s Independent Data Monitoring Committee based on clear positive efficacy.

Jeffrey B. Simon, JD, co-chair of the National Opioid Litigation Conference, discusses the historic settlement in a multi-district opioid lawsuit in Texas.

Explain to patients that research Is continually evolving and the need for booster shots does not mean the vaccinations do not work.

Patients treated with upadacitinib achieved clinical remission of ulcerative colitis more frequently through weeks 8 and 52 versus the placebo group.

Agency hopes green light for complex drug device combination improves competition and access more affordable medications.

Nucala is an IL-5 antagonist monoclonal antibody (immunoglobulin G1 kappa) for the add-on maintenance treatment of adult and pediatric patients with severe asthma and with an eosinophilic phenotype.

Zegerid is indicated for the treatment of frequent heartburn.